We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
10 Year Est. Return
AUM
$1.27B
AUM Growth
-$242M
Cap. Flow
-$285M
Cap. Flow %
-22.45%
Top 10 Hldgs %
6.3%
Holding
1,671
New
346
Increased
361
Reduced
380
Closed
578

Sector Composition

Rank Sector Weight
1 Healthcare 15.59%
2 Technology 14.48%
3 Industrials 10.28%
4 Financials 9.62%
5 Consumer Discretionary 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHX icon
1051
DHI Group
DHX
$166M
$98K 0.01%
+12,843
New +$91.4K
HTCH
1052
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$98K 0.01%
39,045
-157,354
-80% -$372K
ECYT
1053
DELISTED
Endocyte, Inc. Common Stock
ECYT
$96K 0.01%
+14,592
New +$164K
SVU
1054
DELISTED
SUPERVALU Inc.
SVU
$96K 0.01%
+1,661
New +$85.7K
PXLW icon
1055
Pixelworks
PXLW
$38.8M
$92K 0.01%
+1,009
New +$74.9K
STEW
1056
SRH Total Return Fund
STEW
$1.75B
$92K 0.01%
10,800
-38,220
-78% -$318K
ACGN
1057
DELISTED
Aceragen Inc
ACGN
$90K 0.01%
+229
New +$94.4K
ATEC icon
1058
Alphatec Holdings
ATEC
$1.27B
$88K 0.01%
4,514
-7,030
-61% -$118K
LEE icon
1059
Lee Enterprises
LEE
$166M
$88K 0.01%
1,973
-21,316
-92% -$892K
IVAC
1060
DELISTED
Intevac Inc
IVAC
$88K 0.01%
+10,972
New +$88.7K
AUQ
1061
DELISTED
AURICO GOLD INC COM
AUQ
$85K 0.01%
19,901
-148,474
-88% -$601K
CYTK icon
1062
Cytokinetics
CYTK
$11B
$84K 0.01%
+17,524
New +$107K
TELL
1063
DELISTED
Tellurian Inc.
TELL
$84K 0.01%
+4,762
New +$74.3K
RGLS
1064
DELISTED
Regulus Therapeutics
RGLS
$81K 0.01%
+84
New +$72K
RLOC
1065
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$81K 0.01%
+11,540
New +$93K
BSIN
1066
Big Sky Industrial
BSIN
$67M
$80K 0.01%
309
-1,316
-81% -$334K
IMI
1067
DELISTED
Intermolecular, Inc.
IMI
$78K 0.01%
+33,621
New +$84K
OHAI
1068
DELISTED
OHA Investment Corporation
OHAI
$77K 0.01%
+12,325
New +$80.1K
FCSC
1069
DELISTED
Fibrocell Science Inc.
FCSC
$75K 0.01%
+1,248
New +$69.6K
SMSI icon
1070
Smith Micro Software
SMSI
$14M
$71K 0.01%
424
-473
-53% -$93.9K
DMK
1071
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$68K 0.01%
+202
New +$79.3K
SIRI icon
1072
SiriusXM
SIRI
$10B
$65K 0.01%
1,878
-1,091
-37% -$35.5K
ATHX
1073
DELISTED
Athersys, Inc. Common Stock
ATHX
$62K ﹤0.01%
1,380
-6,237
-82% -$307K
PLX icon
1074
Protalix BioTherapeutics
PLX
$191M
$56K ﹤0.01%
1,546
-8
-0.5% -$323
CACB
1075
DELISTED
Cascade Bancorp
CACB
$54K ﹤0.01%
+10,328
New +$49.5K

Similar funds

TFS Capital's Q2 2014 Portfolio in Review

As of Q2 2014, TFS Capital held 1,671 positions worth $1.27B, down 16% from $1.51B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

TFS Capital withdrew a net $285M in Q2 2014, closing 578 positions and reducing 380 holdings. Its most notable exit was ZALE CORPORATION, an estimated $6.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.

Against the trend, TFS Capital opened a new position in Tech Data Corp worth $5.32M.

  • TFS Capital's largest Q2 2014 buy was Tech Data Corp: 85,151 shares worth $5.32M.
  • TFS Capital added most to Prothena Corp in Q2 2014, an estimated $7.16M increase.
  • TFS Capital's biggest Q2 2014 reduction was RF MICRO DEVICES INC, cutting an estimated $7.01M.
  • TFS Capital fully exited ZALE CORPORATION in Q2 2014, selling an estimated $6.08M.
  • TFS Capital's ten largest holdings make up 6.3% of its $1.27B portfolio in Q2 2014.
  • TFS Capital opened 346 new positions and closed 578 in Q2 2014.
  • TFS Capital's portfolio value fell 16% quarter-over-quarter to $1.27B.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.